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Behavioral Interventions to Prevent HIV Transmission and
Acquisition for Transgender Women: A Critical Review
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Abstract: Worldwide, transgender women are at disproportionately
higher risk of HIV infection, with the primary mode of infection
being condomless anal intercourse. Although very few HIV pre-
vention interventions have been developed and tested speciﬁcally for
transgender women, growing evidence suggests that behavioral HIV
risk reduction interventions for other marginalized groups are
efﬁcacious. We outline the current state of knowledge and areas in
need of further development in this area.
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INTRODUCTION
Background
HIV Risk Among TW
Globally, the prevalence of HIV and other sexually
transmitted infections (STIs) is disproportionately higher among
transgender women (TW), particularly ethnic minority and
younger TW. Because HIV-related surveillance data are not
uniformly collected by gender identity, data on HIV infection
among TW are lacking; however, data from local health
departments, meta-analyses, and multi-city studies using con-
venience sampling methods demonstrate high levels of HIV
infection among TW in the United States and other countries
worldwide.1 A meta-analysis of the global burden of HIV
infection in TW documented an HIV prevalence of 19% (95%
CI: 17 to 21); TW had a 49-fold increased odds of HIV
infection compared with all adults of reproductive age.2 In the
United States, a meta-analysis of 29 studies with TW3 showed
an HIV prevalence of 28% through laboratory-conﬁrmed blood
samples (4 studies) and 12% through self-report (18 studies).
Data from local testing of over 500 TW with no known
previous positive HIV test results in Miami, San Francisco, and
Los Angeles found 12% HIV infection, suggesting a high
percentage of undiagnosed HIV infection in this population.4 In
an analysis of these newly diagnosed HIV infections by age, the
highest number were detected among those ages 20–29 years
(ie, 45% of all cases).4 Studies among young TW, in particular
ages 16–29 years, have documented prevalence of HIV
infection approaching those of adults.5–7 In addition, Garofalo
et al found that much like in other high-risk populations (ie,
men who have sex with men; MSM), racial/ethnic minority TW
have higher prevalence of HIV and STIs but lower rates of
sexual risk behavior, particularly among Black TW.5
Condomless anal intercourse (CAI) represents TW’s
primary risk for HIV acquisition and transmission. In the
review of 29 U.S. studies referred to above, the average
prevalence of any receptive CAI was 44%; 32% of TW
reported multiple sex partners (primarily nontransgender
males) and 48.3% reported sex with casual partners
(within varying recall periods).3 Among younger TW in
Chicago, Garofalo et al5 found 59% reported any CAI in
the last year (49% receptive and 37% insertive). Reisner
et al8 found a similar estimate of 52% recent CAI among
a cohort of younger TW in Boston. Although evidence
among TW speciﬁcally is not available, recent ﬁndings
among MSM suggest that inconsistent condom use during
anal sex with HIV-infected partners offers little to no
protection against HIV infection, and that consistent
condom use over time is rare.9
There are speciﬁc structural, developmental, and inter-
personal challenges to sexual safety faced by TW. Social
structures and conditions include discrimination, mistreatment,
and adversity in the form of rejection from friends, family, and
others, which can become a central part of TW’s experi-
ence,5,7,10–13 affecting the ability to secure housing, employ-
ment, social services, and health care beginning in early
adulthood. This basic struggle for survival undermines TW’s
ability to prioritize and practice safer sex.14,15 In addition,
transactional sex is associated with CAI and HIV infection in
From the *Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago,
IL; †Feinberg School of Medicine, Northwestern University; ‡Boston
Children’s Hospital, Harvard Medical School, Harvard T.H. Chan School
of Public Health; and §Harvard T.H. Chan School of Public Health,
Boston, MA, Brown University School of Public Health, Providence, RI.
Research reported in this publication was supported by the National Institute
of Mental Health of the National Institutes of Health under Award
Number R01MH094323. The project described was also supported, in
part, by the Northwestern University Clinical and Translational Science
Institute, Grant Number UL1TR000150 from the National Center for
Advancing Translational Sciences, Clinical and Translational Sciences
Award (CTSA). The content is solely the responsibility of the authors and
does not necessarily represent the ofﬁcial views of the NIH. The CTSA is
a registered trademark of the U.S. Department of Health and Human
Services (DHHS).
The authors have no conﬂicts of interest to disclose.
Correspondence to: Robert Garofalo, MD, MPH, Ann & Robert H. Lurie
Children’s Hospital of Chicago, 225 E. Chicago Avenue, #161, Chicago,
IL 60611 (e-mail: rgarofalo@luriechildrens.org).
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. This is an
open access article distributed under the terms of the Creative Commons
Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND),
which permits downloading and sharing the work provided it is properly
cited. The work cannot be changed in any way or used commercially.
S220 | www.jaids.com J Acquir Immune Defic Syndr  Volume 72, Supplement 3, August 15, 2016
TW, and economic pressures often result in TW compromising
safer sex practices for monetary incentives.16–19 Previous
studies of TW suggest high prevalence of previous incarcer-
ation (;20%),20 largely related to arrest and conviction for
commercial sex work. Evidence suggests that both history of
sex work and incarceration are related to the psychosocial
factors, which often drive HIV risk.21 Furthermore, the legal
problems encountered by TW may serve as barriers to HIV-
related services and access to health care.22
The HIV prevention and care continuum is not well-
characterized in TW, although evidence is emerging of low
prevalence of care initiation and engagement.23–26 Pre-exposure
prophylaxis (PrEP) efﬁcacy and demonstration projects provide
evidence of safety, tolerability, and efﬁcacy of PrEP to prevent
HIV acquisition,27–29 with some evidence of effectiveness in
TW.30 The limited studies conducted to date suggest that
initiation and uptake of PrEP among TW is alarmingly low
despite the complex proﬁles of HIV risk in this group. Analysis
of data from an ongoing interventional study of younger TW
found that only 5% of the sample had initiated PrEP, although
62% were indicated for PrEP based on Centers for Disease
Control and Prevention (CDC) criteria; furthermore, only 31%
of the sample had ever heard of PrEP, but 69% expressed
interest once PrEP was described.31 This is echoed by 2
California-based studies: one study of TW in San Francisco,
which demonstrated that fewer than 20% of TW had ever heard
of PrEP32; and a second qualitative study of 30 MSM and TW
in 3 California metro areas suggesting that while awareness of
PrEP was relatively low, expressed interest once PrEP was
described was quite high (76%).33 Although very little research
has been performed about TW within the HIV continuum of
care, limited evidence suggests that HIV-infected TW are less
likely than other groups to be on antiretroviral therapy (ART)
and, if on ART, are less likely to be adherent.24,34 There is also
some evidence suggesting that transgender-speciﬁc factors are
related to ART adherence in adult TW, including gender
afﬁrmation and adherence to cross-sex hormone therapy.26
HIV Prevention Interventions for TW
Despite research documenting high prevalence of CAI
and HIV infection among TW, there are no interventions
developed speciﬁcally for TW in the CDC compendium
of evidenced-based interventions. Only 5 U.S.-based HIV
prevention interventions have been published in the peer-
reviewed literature; all of which are early-phase non-
randomized interventions (Table 1; see Poteat et al40 for
a review of global interventions).
Four of these studies (Bockting, Nemoto, Taylor, and
Garofalo)35,36,38,39 documented modest reductions in HIV risk
and/or improvements in HIV knowledge and attitudes among
TW, with some evidence that effects diminished over time
(Bockting).35 Three of the studies (Bockting, Taylor, and
Garofalo) reference a speciﬁc behavioral theory as part of
their formative intervention development.
Theoretical Models for HIV Risk Reduction
Interventions Among TW
Interventions designed to change behaviors such as
reductions in the risky sexual activities that lead to the
acquisition or transmission of HIV infection should be theory
based.41 Using a theoretical framework to guide the contents
of an HIV prevention intervention provides a means to
empirically test the mechanisms of change (ie, the underly-
ing theoretical constructs—hypothesized mediators—that
produce a desired change in a behavioral health outcome).
Whether implicitly or explicitly, nearly all HIV prevention
interventions are informed or based on on some element of
behavioral theory. Most rely at least somewhat on the
assumption that providing information and education about
HIV transmission and prevention may lead to behavioral
change. Yet research has proven time and time again that
education alone is insufﬁcient to induce effective behavioral
change among most individuals.42–44 Thus, behavioral
interventions were developed based on psychosocial and
cognitive approaches that may, for example, educate indi-
viduals in practical skills and enhance their conﬁdence in
their ability (ie, self-efﬁcacy) to reduce their risk for HIV.45
A number of behavioral change theories and models have
demonstrated efﬁcacy across diverse populations including
the Health Belief Model,46,47 Social Cognitive Theory,48
Transtheoretical Stages of Change Model,49 the Theory of
Reasoned Action,50 and the Information, Motivation, and
Behavior (IMB) Model.51 None of these models are speciﬁc
to TW, meaning that they do not by deﬁnition provide
a conceptual target for the unique underlying mechanisms of
HIV risk among this population. However, 2 have been
explicitly applied in previously published HIV prevention
interventions for TW: the Health Belief Model (Bockting)
and the IMB Model (Taylor).
Researchers have increasingly come to realize that for
TW, sexual risk behaviors occur in the context of complex
socio-cultural factors and environmental determinants of risk,
such stigma or discrimination based on transgender status,
housing and/or economic instability, and/or transactional sex
and that these factors must be considered when designing HIV
prevention interventions for this group.18,52 As such, other
developmental theories not speciﬁc to behavioral change have
been used as heuristic models to inform the foci of inter-
ventions on transgender-speciﬁc social, cultural, and structural
inﬂuence on sexual risk. For example, the LifeSkills interven-
tion by Garofalo et al used a community-based participatory
research approach and Bronfenbrenner’s Social Ecological
Theory to guide intervention development for considering the
potential impact of discrimination and stigma, as well as related
socio-contextual challenges, such as securing housing, employ-
ment, and appropriate health care on HIV risk behaviors such
as CAI for young TW. Much like the behavioral change
models above, Bronfenbrenner’s theory is not speciﬁc to
conditions affecting young TW but can be applied broadly in
a holistic context grounded in this population’s social realities.
In recent years, at least 2 transgender-speciﬁc heuristic
frameworks have been presented in the published literature
that may hold promise for consideration in the design of
future HIV prevention interventions for TW. Operario and
Nemoto52 described the application of syndemic theory or
the concept of multiple co-occurring psychosocial health
problems speciﬁc to HIV risk among TW. This was
followed by an empirical test by Brennan and colleagues21
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among 151 young TW ages 16–24 years in Chicago and Los
Angeles. They report evidence that multiple health-related
psychosocial factors form a syndemic index (eg, low self-
esteem, polysubstance use, intimate partner violence, vic-
timization related to transgender identity) among younger
TW, which was positively and additively related to sexual
risk behaviors and prevalent HIV infection. In addition, the
syndemic index was related to 2 indicators of social
marginalization: transactional sex and incarceration. Seve-
lius53 collected data from 22 qualitative interviews with TW
of color from the San Francisco Bay Area used an
intersectional approach integrating prominent theories from
stigma, body objectiﬁcation, and HIV-related research to
propose a gender afﬁrmation framework for HIV risk among
this population. Gender afﬁrmation refers to an interper-
sonal, interactive process whereby a person receives social
recognition and support for their gender identity. This
framework conceptualizes that the need for gender afﬁrma-
tion among TW is related to engagement in high-risk
behaviors and negative health outcomes, such as the
acquisition of HIV infection. Overall, the evolution of
behavioral models for understanding HIV risk behaviors
among TW is a relatively nascent ﬁeld and more work needs
to be performed to better deﬁne and elucidate pathways of
risk and resilience.
Case Study/Lessons Learned: LifeSkills
In 2011, after a successful pilot funded by the CDC,
LifeSkills became the ﬁrst full-scale, randomized controlled
trial (RCT) examining the efﬁcacy of a group-based,
empowerment-focused behavioral intervention for HIV pre-
vention among TW funded by the National Institutes of
Health. Given the importance of behavioral theory for HIV
prevention interventions as discussed above, we reviewed the
LifeSkills intervention content for both behavioral change and
transgender-speciﬁc theoretical approaches and proposed
measurement and analysis of these factors (eg, IMB change;
empowerment; transgender adaptation and integration) as
potential mediators of the intervention effect, ie, beyond the
original broad and heuristic framework that informed inter-
vention development. We recruited 300 young TW ages 16–
29 years, in 2 U.S. cities (Chicago and Boston) who were
randomly assigned 2:2:1 in a 3-arm trial (LifeSkills, standard-
of-care, and time-matched attention control). In this ongoing
trial, participants are followed for 1 year with major
assessment visits at baseline, 4, 8, and 12-months postran-
domization. Participants were recruited and enrolled between
2012 and 2015, with follow-up visits ongoing through
September 2016. Participants were racially/ethnically diverse:
49% Black, 12% Latina, 25% White, and 14% other. At
enrollment, 22% of participants were HIV infected (3%
previously undiagnosed). Proposed outcome measures
included condomless sex acts (eg, both anal and vaginal),
as well as the collection of biological specimens for
urogenital STIs (eg, gonorrhea and chlamydia) and HIV-
antibody screening. In this study, we present 6 lessons learned
from this trial for consideration in the design of future HIV
prevention efforts focused for TW:
• Ethics of the RCT: RCTs for behavioral HIV prevention
research can pose a number of fundamental ethical issues to
which researchers and study staff working with TW must
give careful consideration. Although a RCT may be the
preferred method of demonstrating efﬁcacy of a behavioral
intervention, the community may not understand or accept
the randomization process particularly in the context of an
“epidemic” of HIV infection among TW. In particular in
Chicago, where a within person, preposttest design was used
during the pilot study,39 the change to the RCT design as
part of the current full-scale efﬁcacy trial created, at times,
TABLE 1. Published Behavioral HIV Prevention Interventions Among TW
Author Intervention Description Sample Size Design
Theoretical
Model Effects Funder
Bockting et al35 Prevention education
workshop conducted over 3
afternoons
N = 59 Prepost Health Belief
Model
Increase in HIV-related
knowledge and attitudes,
diminished over time; no
signiﬁcant change in risk
behavior
American Foundation for
AIDS Research
Nemoto et al36 18 workshops regarding: (1)
sex, relationships, and
health; (2) substance use,
coping skills; and (3) life
needs
N = 109 (completed
at least 10
workshops)
Prepost N/A Signiﬁcant reductions in
level of sexual risk; no
signiﬁcant change in
HIV knowledge
Substance Abuse and
Mental Health Services
Administration
DeSantis et al37 A 1-day HIV prevention
program based on Many
Men, Many Voices (3MV)
and a community needs
assessment
N;50 Prepost N/A No formal outcomes
evaluation
Gilead Sciences
Taylor et al38 4 group sessions delivered
over 4 days (stress, stigma,
drugs/alcohol, growth/
social support)
N = 55 Prepost IMB Signiﬁcant reduction in
sexual risk
CDC
Garofalo et al39 6 group sessions delivered
over a 3-wk period
N = 51 (ages 16–24) Prepost Social Ecological
Theory
Signiﬁcant reduction in
sexual risk
CDC
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a lack of buy-in from community partners and participants.
Alternative methods such as crossover or waitlist-controlled
designs should be considered, or whenever possible the use
of historical controls or another observational method, to be
maximally responsive to the needs of the community.
• The 3-Arm Design: We found that there were a number of
disadvantages to a 3-arm design and few beneﬁts. The
disadvantages included additional recruitment burden of
a relatively rare population and the loss of sample size for
the primary outcomes comparison. In addition, some partic-
ipants provided feedback that the time-matched attention
control did not address relevant psychosocial concerns and
was an unnecessary time burden.
• Involving the Community: LifeSkills was developed using
a community-participatory design. We involved key
members of the target population in all aspects of the
curriculum development, as well as the study design and
procedures. This proved to critically important to our
successful recruitment and retention efforts throughout the
project period.
• Selection of Biological Specimens: Baseline prevalence
and incidence of urogenital STIs was very low hampering
the use of these data when interpreting the potential impact
of the behavioral intervention on surrogate makers of HIV
infection. We know from the published literature that rectal
STIs and syphilis are indicators of risk for HIV infection in
Black MSM27; however, to date, there are no similar
studies focused on the link between STI diagnosis and HIV
risk in TW. As the National Institutes of Health has
increasingly prioritized biological outcomes within the
context of behavioral HIV prevention research, it will be
important to broaden the collection of specimens to include
both rectal STIs and syphilis whenever possible.
• High Seroprevalence of HIV Infection at Baseline: As
mentioned above, the baseline HIV seroprevalence for our
sample was 22% (3% previously undiagnosed). This
seroprevalence is considerably higher than our team’s
previous experience conducting HIV prevention interven-
tions with MSM and young MSM, but consistent with
other community-based, convenience samples of HIV
prevalence among young TW.5–7 The high seroprevalence
is particularly concerning given the relatively young age of
our study population (eg, ages 16–29 years). Lessons
learned from this ﬁnding include the need for interventions
to be developed and implemented at young ages, as well as
to develop interventions or to include elements of second-
ary prevention that target not just sexual risk behaviors but
all outcomes across the HIV care continuum.
• Intervention Delivery and the Small Group–Based Format:
In both our pilot work and RCT, the LifeSkills intervention
was delivered in 2-hour small-group sessions twice per
week for 3 consecutive weeks. In the RCT, the overall
attendance rate was 79%. Lessons learned regarding the
format and session attendance included (1) safety concerns
for travel to study sites; (2) difﬁculty with attendance for
participants engaged in sex work because of competing
economic needs; (3) some eligible participants were unable
to attend sessions at a speciﬁc date and time because of
competing work or school schedules; (4) because of
a high rate of incarceration history in the sample (29%),
participants on house arrest were unable to attend sessions
because of restricted movement; and (5) while the group-
based sessions were empowering for many participants (ie,
meeting other young TW), staff reported problems with the
group-based dynamic, including mistrust among partici-
pants (eg, fear of personal disclosure) and failure to share
vulnerabilities. As such, consideration for future interven-
tions may be more individualized approaches, a hybrid
design with individual- and group-based components, or
the use of mobile platform, to increase the reach, accessi-
bility, and privacy of the intervention.
Other Future Directions and Priority
Research Areas
One of the current limitations of the published behav-
ioral interventions designed to prevent transmission and
acquisition of HIV among TW is that each was designed
and implemented before the advent of PrEP. PrEP is a once-
daily ﬁxed combination of tenofovir disoproxil fumarate and
emtricitabine that has been shown to reduce the risk of HIV
transmission. Studies of PrEP speciﬁcally in TW have not
been conducted. The iPrEx study of PrEP in MSM and TW
found a 44% risk reduction using an intention-to-treat
analysis.29 A sub analysis of only the TW in the iPrEx
sample found evidence of protection in the context of
medication adherence, despite the lack of efﬁcacy using an
intention-to-treat analysis.30 Furthermore, in this analysis,
there was evidence of both greater sexual risk for HIV
acquisition among TW (versus MSM; more frequent reports
of transactional sex, condomless receptive anal intercourse,
and multiple partners) and lower medication adherence (per
drug concentrations regardless of use of feminizing hor-
mones).30 In our LifeSkills sample, PrEP seemed to be being
underused as an HIV prevention strategy among the young
TW. Despite 2014, clinical guidelines recommending that
PrEP be considered for people who are HIV negative and at
substantial risk for the acquisition of HIV infection, including
anyone who is in an ongoing sexual relationship with an HIV-
infected partner, in the LifeSkills sample 62% had a clinical
indication for PrEP, yet only 5% had ever taken PrEP.
Clearly, further prioritization and study of PrEP in TW,
particularly in context and in concert with behavioral
interventions are warranted, as combination biobehavioral
approaches may hold the greatest promise for reducing HIV
transmission in this high-risk population.
As the next generation of behavioral and biobehavioral
approaches to reduce HIV risk and transmission among TW
are developed it will be important to move beyond group-
level interventions, which have been the mainstay of efforts to
date. Approaches that have shown promise in other popula-
tions like MSM such as couples-based approaches54 or the use
of social networks55 also warrant consideration among TW. In
addition, the use of mobile technology may offer convenient
access and privacy to interventions, and present an opportu-
nity to test a method amenable for widespread dissemina-
tion,56 which is especially important for a relatively rare, often
isolated, and highly stigmatized population such as TW who
can be difﬁcult to reach and engage. Finally, given the
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profound socioeconomic instability—which far-too-often is
a social reality for TW—and its inﬂuence on the initiation and
engagement in high-risk behaviors such as transactional sex,
the development of structural approaches such as employment
and vocational interventions and initiatives should be strongly
considered and prioritized because they may offer the greatest
promise at holistically improving the lives of TW, including
holding promise for the reduction of HIV transmission.
In conclusion, few theory-based behavioral interven-
tions designed to reduce HIV risk or HIV incidence currently
exist in the published literature for TW. Given the epidemic
that currently exists of HIV infection among this population,
there is a critical and urgent need for additional behavioral,
biobehavioral, and structural approaches, which target the
unique mechanisms of HIV risk for TW and those are
grounded in both behavioral theory and the often harsh social
realities facing this population.
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